Bristol-Myers Squibb Co. (BMY) PT Lowered to $60 at Barclays
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $64.63 --0%
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Join SI Premium – FREE
Barclays analyst Carter Gould lowered the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $60.00 (from $62.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Alpha Cognition Inc (ACOG) PT Raised to $20 at H.C. Wainwright
- Kikkoman (2801:JP) PT Raised to JPY2,200 at JPMorgan
- Sumitomo Mitsui Financial Group (8316:JP) (SMFG) PT Raised to JPY8,220 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
